|
|||||
|
|
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study |
|
| Authors: | Riccardo Danielli Roberto Patuzzo Anna Maria Di Giacomo Gianfranco Gallino Andrea Maurichi Annabella Di Florio Ornella Cutaia Andrea Lazzeri Carolina Fazio Clelia Miracco Leonardo Giovannoni Giuliano Elia Dario Neri Michele Maio Mario Santinami |
| Institution: | 1. Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy 2. Melanoma and Sarcoma Unit, Department of Surgery, National Tumor Institute, Via G. Venezian, 1, 20133, Milan, Italy 3. Section of Pathological Anatomy, Department of Medicine, Surgery, and Neuroscience, University of Siena, Siena, Italy 4. Philogen S.p.A., Siena, Italy 5. Philochem AG, Otelfingen, Switzerland 6. Swiss Federal Institute of Technology (ETH), Zurich, Switzerland |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |